Canada - Tiếng Pháp - Health Canada

jamp pharma corporation - polystyrène sulfonate de sodium - poudre pour suspension - 1g - polystyrène sulfonate de sodium 1g - potassium-removing agents

Canada - Tiếng Pháp - Health Canada

pharmascience inc - polystyrène sulfonate de sodium - poudre pour suspension - 1g - polystyrène sulfonate de sodium 1g - potassium-removing agents

Canada - Tiếng Pháp - Health Canada

pharmascience inc - polystyrène sulfonate de sodium - suspension - 250mg - polystyrène sulfonate de sodium 250mg - potassium-removing agents

Vương quốc Anh - Tiếng Anh - MHRA (Medicines & Healthcare Products Regulatory Agency)

waymade healthcare plc - calcium polystyrene sulfonate - powder for oral or rectal suspension - 999mg/1gram

Vương quốc Anh - Tiếng Anh - MHRA (Medicines & Healthcare Products Regulatory Agency)

mawdsley-brooks & company ltd - calcium polystyrene sulfonate - powder for oral or rectal suspension - 999mg/1gram

Kenya - Tiếng Anh - Pharmacy and Poisons Board

mega lifesciences public company ltd 384 , soi 6, bangpoo industrial estate , pattana - calcium polystyrene sulfonate - powder for oral/rectal suspension - each sachet contains calcium polystyrene… - polystyrene sulfonate

Úc - Tiếng Anh - Department of Health (Therapeutic Goods Administration)

catalent australia pty ltd - polystyrene sulfonate - calcium -

Bỉ - Tiếng Pháp - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

sanofi belgium sa-nv - polystyrène sulfonate sodique 14,99 g - poudre pour suspension oral/rectal - 14,99 g - polystyrène sulfonate sodique 999.9 mg/g - polystyrene sulfonate

Malaysia - Tiếng Anh - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

averroes pharmaceuticals sdn. bhd. - calcium polystyrene sulfonate -

Hoa Kỳ - Tiếng Anh - NLM (National Library of Medicine)

paddock laboratories, llc - sodium polystyrene sulfonate (unii: 1699g8679z) (polystyrene sulfonic acid - unii:70ko0r01ry) - sodium polystyrene sulfonate 15 g in 60 ml - kionex® suspension is indicated for the treatment of hyperkalemia. kionex® suspension is contraindicated in the following conditions: patients with hypokalemia, patients with a history of hypersensitivity to polystyrene sulfonate resins, obstructive bowel disease, oral or rectal administration in neonates (particularily in premature infants), and in any post-operative patient until normal bowel function resumes (see precautions).